- Chapel Hill:984-528-7215
- Fax #:919-869-2421
- ketaminewellness@ketwell.com
- Open Daily by Appointment Only
All Departments
OCD
OCD Treatment
Obsessive-Compulsive Disorder (OCD) is a medical condition in which a person has uncontrollable, recurring thoughts (obsessions) and behaviors (compulsions). OCD is quite common; nearly 1 out of every 40 people are diagnosed with OCD during their lifetime.
Obsessions are defined as irrational, intrusive thoughts that occur repeatedly. Individuals with OCD are typically aware of their obsessions/compulsions and often time find them very distressing but are unable to control them.
Compulsions are defined as repetitive acts that serve to relieve the stress brought on by an obsession. Patients with OCD know that these repetitive “rituals” dont make sense but are compelled to perform them to relieve the fear that something bad may result if not performed.
These symptoms can be mild, or can interfere with all aspects of one’s life, including school, work and interpersonal relationships.
As with many other mental health conditions, traditional treatments for OCD include psychotherapy, behavioral therapy and antidepressant medications. Often, however, patients do not respond to these treatments.
The Ketamine Wellness Institute offers low-dose Ketamine infusions in a safe and relaxing environment to patients suffering from OCD by an anesthesiologist with years of experience.
Please note that although Ketamine has brought relief to thousands of patients, it is not a permanent cure. Once a patient’s mood is stabilized with Ketamine, maintenance infusions are required once every one to six months for most patients. At the Ketamine Wellness Institute, we will work closely with your primary care physician to provide you with the most comprehensive wellness plan possible. We are committed to your care.
“Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept” — Neuropsychopharm, 2013
“Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial” — The Journal of Clinical psychiatry, 2016